Mainstream

Rani Therapeutics GAAP EPS of -$0.22, revenue of $0.17M

Rani Therapeutics GAAP EPS of -$0.22, revenue of $0.17M

Post ContentraniRead More

You might also be interested in reading YieldMax Ultra Option Income Strategy ETF declares $0.1029 dividend.

May 14, 2025
In Mainstream